BRIAN BRENNAN: Open Payments
NPI 1487298725 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,772 in 148 payments from 14 companies in 2025. Trend: 2023 $2,084 · 2024 $2,887 · 2025 $2,772
Food & beverage: $2,772
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 52 | $817 |
| Gilead Sciences, Inc. | 24 | $507 |
| Lilly USA, LLC | 18 | $342 |
| AstraZeneca Pharmaceuticals LP | 11 | $222 |
| Merck Sharp & Dohme LLC | 7 | $200 |
| Theratechnologies Inc. | 8 | $172 |
| Amgen Inc. | 6 | $103 |
| Novo Nordisk Inc | 6 | $93 |
| Napo Pharmaceuticals Inc | 4 | $87 |
| ABBVIE INC. | 3 | $73 |
Products named: MOUNJARO, APRETUDE, DOVATO, CABENUVA, PIFELTRO, EGRIFTA, RUKOBIA, Mytesi.
Industry payments across MO — which companies pay providers there.
